GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $369,000 | -7.8% | 11,550 | 0.0% | 0.01% | +14.3% |
Q1 2022 | $400,000 | +18.3% | 11,550 | 0.0% | 0.01% | +16.7% |
Q4 2021 | $338,000 | +15.0% | 11,550 | 0.0% | 0.01% | +20.0% |
Q3 2021 | $294,000 | -27.2% | 11,550 | 0.0% | 0.01% | -37.5% |
Q2 2021 | $404,000 | -14.2% | 11,550 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $471,000 | -5.8% | 11,550 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $500,000 | -21.5% | 11,550 | 0.0% | 0.01% | -33.3% |
Q3 2020 | $637,000 | -12.6% | 11,550 | 0.0% | 0.02% | -16.7% |
Q2 2020 | $729,000 | +23.6% | 11,550 | 0.0% | 0.02% | +5.9% |
Q1 2020 | $590,000 | -35.7% | 11,550 | -0.0% | 0.02% | -19.0% |
Q4 2019 | $918,000 | +63.6% | 11,553 | 0.0% | 0.02% | +50.0% |
Q3 2019 | $561,000 | -7.7% | 11,553 | +0.0% | 0.01% | -12.5% |
Q2 2019 | $608,000 | -0.5% | 11,550 | 0.0% | 0.02% | 0.0% |
Q1 2019 | $611,000 | -31.0% | 11,550 | -46.4% | 0.02% | -40.7% |
Q4 2018 | $885,000 | +8.1% | 21,550 | 0.0% | 0.03% | +17.4% |
Q3 2018 | $819,000 | -15.9% | 21,550 | 0.0% | 0.02% | -20.7% |
Q2 2018 | $974,000 | -6.4% | 21,550 | 0.0% | 0.03% | -9.4% |
Q1 2018 | $1,041,000 | -4.1% | 21,550 | -21.9% | 0.03% | 0.0% |
Q4 2017 | $1,086,000 | +48.4% | 27,604 | +17.1% | 0.03% | +39.1% |
Q3 2017 | $732,000 | +22.4% | 23,580 | +7.8% | 0.02% | +27.8% |
Q2 2017 | $598,000 | +16.6% | 21,879 | +57.3% | 0.02% | +12.5% |
Q1 2017 | $513,000 | – | 13,909 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |